July 31, 2024 06:04 PM EDTUpdated August 1, 01:10 AM
Pharma
FDA+
Law

Judge re­jects No­vo Nordisk's IRA case as pric­ing ne­go­ti­a­tions con­clude

Nicole DeFeudis

Editor

A New Jer­sey fed­er­al judge has sided with the fed­er­al gov­ern­ment in No­vo Nordisk’s law­suit against the In­fla­tion Re­duc­tion Act, an­oth­er in a string of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times